









Markets
/
Stocks
/
nasdaq-jazz
/

Jazz Pharmaceuticals PLC

JAZZ

View Detailed Chart

115.520USD

+0.890+0.78%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

7.12BMarket Cap

14.76P/E TTM



Jazz Pharmaceuticals PLC

115.520

+0.890+0.78%

Overview Company Financials

Financials

Intraday

30m

Today

+0.78%

5 Days

-2.29%

1 Month

+5.55%

6 Months

-5.29%

Year to Date

-6.20%

1 Year

+2.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 19 analysts

BUY

Current Rating

186.071

Target Price

61.07%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Jazz Pharmaceuticals PLC

JAZZ

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(5)

Buy(4)

Indicators

Sell(1)

Neutral(5)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.128

Neutral

RSI(14)

55.951

Neutral

STOCH(KDJ)(9,3,3)

52.895

Neutral

ATR(14)

2.803

High Vlolatility

CCI(14)

-42.744

Neutral

Williams %R

47.425

Neutral

TRIX(12,20)

0.296

Sell

StochRSI(14)

25.908

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

116.049

Sell

MA10

116.282

Sell

MA20

114.072

Buy

MA50

110.887

Buy

MA100

113.729

Buy

MA200

118.694

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection. The Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution product is for the treatment of cataplexy or excessive daytime sleepiness (EDS), in patients with narcolepsy seven years of age and older. The Xyrem (sodium oxybate) oral solution product is for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older. The Defitelio (defibrotide sodium) product is for the treatment of hepatic veno-occlusive disease (VOD).

Ticker SymbolJAZZ

CompanyJazz Pharmaceuticals PLC

CEOMs. Renee D. Gala

Websitehttps://www.jazzpharma.com/